Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185107 · ClinicalTrials.gov registry record · Phase 4
Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol
A Phase 4 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00185107 is a Phase 4 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 45 participants.
The verdict
NCT00185107, a Phase 4 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
Assess the efficacy of WelChol® plus Zetia® in treating patients with high cholesterol
Interventions
- DRUG Simvastatin
- DRUG Ezetimibe
- DRUG Colesevelam Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2005-03 |
| Est. Completion | 2005-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185107
The ClinicalTrials.gov registry entry for NCT00185107 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Simvastatin is the first listed.
NCT00185107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00185107 about?
NCT00185107 is a clinical study titled "Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol". Assess the efficacy of WelChol® plus Zetia® in treating patients with high cholesterol
What is the current status of trial NCT00185107?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2005-03. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00185107?
The interventions under investigation include: Simvastatin (DRUG), Ezetimibe (DRUG), Colesevelam Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00185107?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.